Dutch start-up, Delta Diagnostics, a leader in label-free, multiplexed biosensing, announced today that it has successfully secured Series A funding of €5.25 million. The funding round was made possible by a consortium of four investors: i&i Biotech Fund, Oost NL, InnovationQuarter and PhotonDelta. The investment will fuel the company’s ambitious vision of making rapid, sensitive, and low-cost biosensors accessible to all, transforming the Life Sciences industry and paving the way for novel and faster solutions in Life Sciences research.
All news
Delta Diagnostics raises €5.25 million in Series A Funding to Revolutionize Biosensing Technology
More news
All newsDutchPhotonicsEvent 2026 Exceeds Expectations
The 2026 edition of the DutchPhotonicsEvent exceeded expectations and was a great success. Held over two days at the 1931 Congress Centre…
The inaugural Photonics Action Day successfully engaged the community.
Held on 2 June, this inaugural edition welcomed the broader Photonics & Optics community, bringing together around 30 participants for a day…
Photonics Powers the Future of Space: Innovation and Security Take Center Stage at the Amsterdam Space Symposium
The historic Beurs van Berlage buzzed with cosmic ambition on March 3 and 4 as the Amsterdam Space Symposium took centre stage.…